Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Sales (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Return on Sales for 12 consecutive years, with 1669.35% as the latest value for Q3 2025.

  • Quarterly Return on Sales fell 164664.0% to 1669.35% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1669.35% through Sep 2025, down 164664.0% year-over-year, with the annual reading at 22.33% for FY2024, N/A changed from the prior year.
  • Return on Sales hit 1669.35% in Q3 2025 for vTv Therapeutics, down from 1404.35% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.49% in Q3 2021 to a low of 3068.33% in Q3 2023.
  • Historically, Return on Sales has averaged 779.18% across 5 years, with a median of 357.78% in 2022.
  • Biggest five-year swings in Return on Sales: tumbled -305423bps in 2023 and later surged 304562bps in 2024.
  • Year by year, Return on Sales stood at 1053.67% in 2021, then surged by 36bps to 676.67% in 2022, then tumbled by -353bps to 3068.33% in 2023, then skyrocketed by 91bps to 261.0% in 2024, then plummeted by -540bps to 1669.35% in 2025.
  • Business Quant data shows Return on Sales for VTVT at 1669.35% in Q3 2025, 1404.35% in Q2 2025, and 1347.24% in Q1 2025.